These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8231385)

  • 1. [Alpha interferon treatment of idiopathic myelofibrosis].
    Cervantes F; Alcorta I; Escoda L; Montserrat E; Rozman C
    Med Clin (Barc); 1993 Oct; 101(13):498-500. PubMed ID: 8231385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alfa-2b interferon in the treatment of thrombocytosis associated to chronic non leukemic myeloproliferative syndromes].
    Petit J; Callís M; Domingo Albós A; Fernández de Sevilla A; Besses C; Martí JM
    Med Clin (Barc); 1993 Nov; 101(16):601-3. PubMed ID: 8271861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon].
    Gotić M; Cvetković M; Bozanović T; Cemerikić V
    Srp Arh Celok Lek; 2001; 129(11-12):304-8. PubMed ID: 11928616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myelofibrosis: response to recombinant human interferon alpha-2a.
    List AF; Kummet TD; Kerr DM
    Leuk Res; 1990; 14(4):321-6. PubMed ID: 2332985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate in idiopathic and postpolycythemic myelofibrosis.
    Hasselbalch HC; Bjerrum OW; Jensen BA; Clausen NT; Hansen PB; Birgens H; Therkildsen MH; Ralfkiaer E
    Am J Hematol; 2003 Dec; 74(4):238-42. PubMed ID: 14635203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia].
    Barosi G; Liberato NL; Costa A; Ascari E
    Haematologica; 1990; 75 Suppl 4():48-50. PubMed ID: 2074054
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Costa A; Ascari E
    Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of interstitial pneumonitis associated with natural alpha-interferon therapy for myelofibrosis.
    Nakamura F; Andoh A; Minamiguchi H; Hodohara K; Fujiyama Y; Bamba T
    Acta Haematol; 1997; 97(4):222-4. PubMed ID: 9158665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon alpha-2b in the treatment of myelofibrosis.
    Furesi L; Laghi Pasini F; Forconi S
    Haematologica; 1990; 75(6):587-9. PubMed ID: 2098307
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of interferon in the treatment of chronic myeloproliferative disorders].
    Robak T
    Acta Haematol Pol; 1992; 23(2 Suppl 1):30-7. PubMed ID: 1488870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of bone marrow fibrosis in idiopathic myelofibrosis after treatment with alpha-interferon.
    Domingues MA; Haepers AT; Massaut IH; Vassallo J; Lorand-Metze I
    Haematologica; 1998 Dec; 83(12):1124-5. PubMed ID: 9949632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Cervantes F; Hernández-Boluda JC; Alvarez A; Nadal E; Montserrat E
    Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Interferon in myelofibrosis: a case report.
    Dalla KP; Zeigler ZR; Shadduck RK
    Br J Haematol; 1994 Mar; 86(3):654-6. PubMed ID: 8043450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
    Bonaccorso R; Teresi M; Gebbia V; Tambone Reyes M; Tinnirello D; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1266-8. PubMed ID: 16312860
    [No Abstract]   [Full Text] [Related]  

  • 18. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
    Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of alpha2 interferon in the treatment of the chronic myeloproliferative disorders (E5487): a trial of the Eastern Cooperative Oncology Group.
    Radin AI; Kim HT; Grant BW; Bennett JM; Kirkwood JM; Stewart JA; Hahn RG; Dutcher JP; Wiernik PH; Oken MM;
    Cancer; 2003 Jul; 98(1):100-9. PubMed ID: 12833462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha-interferon therapy in Crohn's disease: initial clinical results].
    Wirth HP; Zala G; Meyenberger C; Jost R; Ammann R; Münch R
    Schweiz Med Wochenschr; 1993 Jul; 123(27-28):1384-8. PubMed ID: 8346423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.